GE HealthCare Technologies (GEHC) Cash from Operations (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Cash from Operations came in at 168000000.0 in Q2 2026, up 78.72% YoY from 94000000.0 in Q2 2025, and down 42.07% on a QoQ basis from 290000000.0 in Q1 2026.
GE HealthCare Technologies (GEHC) Cash from Operations (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Cash from Operations data on file, last reported at 168000000.0 in Q2 2026.
- Quarterly Cash from Operations rose 78.72% year-over-year to 168000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2101000000.0 (up 5.1% YoY) and the FY2025 annual result came in at 1987000000.0, up 1.64% from the prior year.
- Cash from Operations eased to 168000000.0 in Q2 2026, from 290000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1063000000.0 in Q4 2022 to a low of 119000000.0 in Q2 2024.
- A 5-year average of 479722222.22 and a median of 468000000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations sank 252.63% — and 2025, when it surged 178.99%.
- Tracing GEHC's Cash from Operations over 5 years: stood at 1063000000.0 in 2022, then dropped by 1.22% to 1050000000.0 in 2023, then slipped by 13.05% to 913000000.0 in 2024, then rose by 15.01% to 1050000000.0 in 2025, then tumbled by 84.0% to 168000000.0 in 2026.
- The last three Cash from Operations figures came in at 168000000.0 (Q2 2026), 290000000.0 (Q1 2026), and 1050000000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 447.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 168.00 Mn |
| Jun 30, 2026 | 168.00 Mn |
| Mar 31, 2026 | 290.00 Mn |
| Mar 31, 2026 | 290.00 Mn |
| Dec 31, 2025 | 1.05 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 593.00 Mn |
| Sep 30, 2025 | 593.00 Mn |
| Jun 30, 2025 | 94.00 Mn |
| Jun 30, 2025 | 94.00 Mn |
| Mar 31, 2025 | 250.00 Mn |
| Mar 31, 2025 | 250.00 Mn |
| Dec 31, 2024 | 913.00 Mn |
| Dec 31, 2024 | 913.00 Mn |
| Sep 30, 2024 | 742.00 Mn |
| Sep 30, 2024 | 742.00 Mn |
| Jun 30, 2024 | -119.00 Mn |
| Jun 30, 2024 | -119.00 Mn |
| Mar 31, 2024 | 419.00 Mn |
| Mar 31, 2024 | 419.00 Mn |